Carisma Therapeutics

Philadelphia, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

Sep 2022

Series C

Biotechnology Health Care Life Science Medical Therapeutics

Top Investors

AbbVieHealthCapIP Group4BIO CapitalBlood Cancer UnitedInc.

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Carisma Therapeutics

Who are Carisma Therapeutics's investors?

Carisma Therapeutics's investors include AbbVie, HealthCap, IP Group, 4BIO Capital, Blood Cancer United, Inc..

Where is Carisma Therapeutics headquartered?

Carisma Therapeutics is headquartered in Philadelphia, United States.

What does Carisma Therapeutics do?

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

What stage is Carisma Therapeutics at?

Carisma Therapeutics is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 21, 2022.

MLA

"Carisma Therapeutics — Funding & Investors." VCBacked, September 21, 2022, https://www.vcbacked.co/company/carisma-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Carisma Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/carisma-therapeutics

Wikipedia (cite web)

{{cite web |title=Carisma Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/carisma-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 21, 2022.